Hypertensive nephropathy medical therapy: Difference between revisions

Jump to navigation Jump to search
(s)
 
Line 3: Line 3:
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


{{CMG}}
{{CMG}}{{AE}}{{NN}}
==Medical therapy==
 
* Lifestyle modification and decreased salt intake
 
* Control hypertension
==Medical therapy<ref name="PughGallacher2019">{{cite journal|last1=Pugh|first1=Dan|last2=Gallacher|first2=Peter J.|last3=Dhaun|first3=Neeraj|title=Management of Hypertension in Chronic Kidney Disease|journal=Drugs|volume=79|issue=4|year=2019|pages=365–379|issn=0012-6667|doi=10.1007/s40265-019-1064-1}}</ref>==
** [[ACE inhibitors]]
 
* Non-pharmacological therapy
**Lifestyle modification and decreased salt intake
***Sodium intake < 50 mmol/day (3 g/day of salt) leads to reduce systolic blood pressure by 10 mmHg.
*** Sodium intake< 100 mmol/day (6 g/day of salt) has been found to decrease proteinuria by 25%.
**Weight loss
* Pharmacological therapy to control hypertension includes:
** [[ACE inhibitors]] or ARB
** [[Diuretics]]: [[loop diuretics]] and [[thiazides]]
** [[Diuretics]]: [[loop diuretics]] and [[thiazides]]
** [[Calcium channel blockers]]
** [[Beta blockers]]
** [[Beta blockers]]
** [[Calcium channel blockers]]
** [[Alpha blockers]]
** AT II inhibitors
** [[Mineralocorticoid receptor blockers]]
** Renin inhibitors
** [[Renin]] inhibitors
 
 


==References==
==References==

Latest revision as of 00:17, 15 June 2020

Hypertensive nephropathy Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Differentiating Hypertensive Nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Abdominal X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertensive nephropathy medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypertensive nephropathy medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertensive nephropathy medical therapy

CDC on Hypertensive nephropathy medical therapy

Hypertensive nephropathy medical therapy in the news

Blogs on Hypertensive nephropathy medical therapy

Directions to Hospitals Treating Hypertensive nephropathy

Risk calculators and risk factors for Hypertensive nephropathy medical therapy

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]


Medical therapy[1]


References

  1. Pugh, Dan; Gallacher, Peter J.; Dhaun, Neeraj (2019). "Management of Hypertension in Chronic Kidney Disease". Drugs. 79 (4): 365–379. doi:10.1007/s40265-019-1064-1. ISSN 0012-6667.

Template:WH Template:WS